This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

The abbreviated new drug application (ANDA) for the product was filed with the USFDA by Granules Pharmaceuticals, Inc. (GPI), ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion ...

Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) ...

On Sept. 13, Zydus Lifesciences signed a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. The pact has been inked for gadobutrol injection, a generic version of ...

Overwhelmed by options in the vitamin aisle? Here's how to choose the best prenatal vitamin, according to OB/GYNs.

On-dose authentication solution promises more direct and foolproof methods of assuring medicines authenticity.

National Ventilation is celebrating winning the ‘Best Customer Service’ award at this year’s prestigious Electrical Wholesaler Awards.

Global pharma major Lupin Limited (Lupin) announced the launch of the first generic version of Pred Forte (prednisolone acetate) ophthalmic suspension USP, 1% in the United States. Being the first ...

The global petroleum jelly industry share is expected to reach a market value of USD 525.1 million in 2023. This may push the ...